Chemoinformaics analysis of Gossypetin 3-glucoside
| Molecular Weight | 480.378 | nRot | 4 |
| Heavy Atom Molecular Weight | 460.218 | nRig | 24 |
| Exact Molecular Weight | 480.09 | nRing | 4 |
| Solubility: LogS | -3.894 | nHRing | 2 |
| Solubility: LogP | -0.26 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 17 |
| nHA | 13 | APOL | 58.8319 |
| nHD | 9 | BPOL | 26.1401 |
| QED | 0.164 |
| Synth | 4.141 |
| Natural Product Likeliness | 2.236 |
| NR-PPAR-gamma | 0.854 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.018 |
| Pgp-sub | 0.397 |
| HIA | 0.677 |
| CACO-2 | -6.338 |
| MDCK | 0.00000962 |
| BBB | 0.01 |
| PPB | 0.883457 |
| VDSS | 0.807 |
| FU | 0.17877 |
| CYP1A2-inh | 0.081 |
| CYP1A2-sub | 0.032 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.044 |
| CYP2c9-inh | 0.019 |
| CYP2c9-sub | 0.094 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.137 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.006 |
| CL | 4.761 |
| T12 | 0.928 |
| hERG | 0.098 |
| Ames | 0.879 |
| ROA | 0.034 |
| SkinSen | 0.835 |
| Carcinogencity | 0.05 |
| EI | 0.299 |
| Respiratory | 0.021 |
| NR-Aromatase | 0.758 |
| Antiviral | Yes |
| Prediction | 0.863891 |